Skip to main content
SpringerLink
Log in

Respiratory syncytial virus-associated hospitalization rates in high-risk populations: an observational comparative cohort analysis

  • Letter to the Editor
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Shi T, McAllister DA, O'Brien KL et al (2017) RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 390:946–948

    Article  Google Scholar 

  2. Resch B, Bramreiter VS, Kurath-Koller S, Freidl T, Urlesberger B (2017) Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis. Eur J Clin Microbiol Infect Dis 36:1057–1062

    Article  CAS  Google Scholar 

  3. Resch B, Gusenleitner W, Mandl C, Müller W (2000) Epidemiology of respiratory syncytial virus infection in Southern Austria. Pediatr Infect Dis J 19:587–588

    Article  CAS  Google Scholar 

  4. Resch B, Gusenleitner W, Müller W (2002) The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years. Infection 30:193–197

    Article  CAS  Google Scholar 

  5. American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134:e620–e638

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Auenbruggerplatz 34/2, 8036, Graz, Austria

    B. Resch & B. Urlesberger

  2. Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical, University of Graz, Graz, Austria

    B. Resch & C. Puchas

Authors
  1. B. Resch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Puchas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Urlesberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Resch.

Ethics declarations

The study was approved by the local ethic committee (No. 28-383 ex 15/16).

Conflicts of interest

BR received honoraria for oral lectures form Abbvie Austria and Germania Pharmaceuticals. The other authors reported none.

Research involving human participants and/or animals

Yes, infants and children.

Informed consent

Not applicable due to the retrospective study design.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Resch, B., Puchas, C. & Urlesberger, B. Respiratory syncytial virus-associated hospitalization rates in high-risk populations: an observational comparative cohort analysis. Eur J Clin Microbiol Infect Dis 37, 2413–2414 (2018). https://doi.org/10.1007/s10096-018-3388-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-018-3388-2

Search

Navigation